Moderna Recalls 764,900 Doses of Spikevax Due to Contamination Problem
Moderna, Inc., developer of the experimental messenger RNA (mRNA) mRNA-1273, or “Spikevax,” biologic, has recalled 764,900 doses in lot #000190A of the product from the European market. On Apr. 8, 2022, the company said that the doses, manufactured under contract to Moderna by Spanish pharmaceutical company ROVI Pharma Industrial Services, SAU, are being pulled out […]
